Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 256,744 shares at $358.23 ($95.1M) on 2025-08-13, disclosed to the SEC on 2025-08-13.
Scheduled sale ($95.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $358.23 | 1,600 | $573K | 0.6% |
| 2 | $359.31 | 455 | $163K | 0.2% |
| 3 | $359.31 | 455 | $163K | 0.2% |
| 4 | $360.27 | 3,153 | $1.1M | 1.2% |
| 5 | $360.27 | 3,153 | $1.1M | 1.2% |
| 6 | $361.13 | 1,754 |
| $633K |
| 0.7% |
| 7 | $361.13 | 1,754 | $633K | 0.7% |
| 8 | $362.29 | 1,439 | $521K | 0.5% |
| 9 | $362.29 | 1,439 | $521K | 0.5% |
| 10 | $363.08 | 2,591 | $941K | 1.0% |
| 11 | $363.08 | 2,591 | $941K | 1.0% |
| 12 | $364.02 | 3,529 | $1.3M | 1.4% |
| 13 | $364.02 | 3,529 | $1.3M | 1.4% |
| 14 | $365.19 | 1,716 | $627K | 0.7% |
| 15 | $365.19 | 1,716 | $627K | 0.7% |
| 16 | $366.22 | 3,152 | $1.2M | 1.2% |
| 17 | $366.22 | 3,152 | $1.2M | 1.2% |
| 18 | $367.31 | 7,119 | $2.6M | 2.8% |
| 19 | $367.31 | 7,119 | $2.6M | 2.8% |
| 20 | $368.34 | 6,788 | $2.5M | 2.6% |
| 21 | $368.34 | 6,788 | $2.5M | 2.6% |
| 22 | $369.44 | 7,992 | $3.0M | 3.1% |
| 23 | $369.44 | 7,992 | $3.0M | 3.1% |
| 24 | $370.44 | 7,877 | $2.9M | 3.1% |
| 25 | $370.44 | 7,877 | $2.9M | 3.1% |
| 26 | $371.53 | 22,710 | $8.4M | 8.9% |
| 27 | $371.53 | 22,710 | $8.4M | 8.9% |
| 28 | $372.39 | 28,976 | $10.8M | 11.3% |
| 29 | $372.39 | 28,976 | $10.8M | 11.3% |
| 30 | $373.35 | 24,166 | $9.0M | 9.5% |
| 31 | $373.35 | 24,166 | $9.0M | 9.5% |
| 32 | $374.38 | 4,155 | $1.6M | 1.6% |
| 33 | $374.38 | 4,155 | $1.6M | 1.6% |
| Total | $370.32 avg | 256,744 | $95.1M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |
| MDGL | SELL | 2025-07-22 | $980K | — | Filing → |